NeoGenomics, Inc. — Form 8-K Summary
Report date: October 5, 2026. The filing announces preliminary financial results for the quarter ended September 30, 2026, and leadership, board and bylaw changes. The referenced press release containing the preliminary results is not included in the supplied filing text.
Financial results and condition
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity or other quarterly financial metrics. It therefore does not permit a financial comparison with the prior-year quarter or another comparable period.
Material developments
- CEO transition: Warren Stone, currently President and Chief Operating Officer, is scheduled to become CEO and join the Board on January 4, 2027. Current CEO Tony Zook is scheduled to become Executive Chairman on that date.
- Stone compensation: Annual base salary of $850,000; target annual bonus of 100% of base salary; and eligibility for annual equity awards beginning in fiscal 2027 with an aggregate target value of approximately $8 million, subject to committee discretion.
- Zook compensation: Annual base salary of $400,000; target annual bonus of 50% of salary; and eligibility for annual restricted-stock-unit awards with an aggregate target value of approximately $3 million, subject to committee discretion.
- Both employment agreements provide severance and equity-vesting provisions for qualifying terminations, with enhanced provisions around a change in control. Payments are subject to a release agreement.
- Board changes: Lynn Tetrault will step down as Chair on January 4, 2027, remain an independent director until the 2027 annual meeting, and has stated she does not intend to stand for reelection. Michael Kelly is scheduled to become Lead Independent Director on January 4, 2027.
- Bylaw amendment: Effective September 30, 2026, the maximum Board size increased from 10 to 11 directors.
Outlook, risks and unusual items
The filing provides no financial guidance or operating outlook figures. It identifies risks to completing the leadership and Board transitions on schedule and without business disruption, maintaining an effective executive team and Board structure, and implementing financial and operational initiatives. It also refers investors to risk factors in the company’s 2025 Form 10-K and subsequent SEC filings.
The Stone agreement summary states that certain severance terms would apply if qualifying termination occurs “prior to January 4, 2026,” although the agreement is effective January 4, 2027. This date appears inconsistent with the surrounding text and should be checked against the full agreement.
Key facts for investors to verify
- Review Exhibit 99.1 and subsequent filings for the preliminary third-quarter results and any revisions or final reported figures.
- Confirm quarterly performance against the comparable prior-year period, including revenue, profitability, cash flow, margins, debt and liquidity.
- Review the full Stone and Zook employment agreements, particularly award terms, severance triggers and the apparent January 4, 2026 date inconsistency.
- Monitor whether the planned executive and Board transitions occur as announced and whether the Board’s leadership structure or size changes further.